Summary of ongoing and planned clinical trials
|
9
|
Zenith Epigenetics
|
Dec 23, 2020 05:25PM
|
Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes
|
7
|
Resverlogix Corp.
|
Sep 13, 2021 09:57AM
|
Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV
|
3
|
Resverlogix Corp.
|
Jul 24, 2019 03:20PM
|
Stonegate Capital Partners Research Report 3/19/2018
|
3
|
Resverlogix Corp.
|
Mar 19, 2018 04:51PM
|
Stonegate Capital Partners Initiates Coverage on Resverlogix
|
8
|
Resverlogix Corp.
|
Nov 05, 2015 04:31PM
|
Still waiting for that BETonMACE CKD sub-study 7 months later
|
8
|
Resverlogix Corp.
|
Jun 11, 2020 09:37AM
|
Still waiting for a sufficient answer
|
7
|
Resverlogix Corp.
|
May 18, 2018 05:16PM
|
STAT News article on Constellation's pan BET inhibitor
|
4
|
Zenith Epigenetics
|
Jun 16, 2020 10:11AM
|
Standard of Care in BETonMACE
|
6
|
Resverlogix Corp.
|
Mar 19, 2019 08:45AM
|
Speculation is warranted
|
8
|
Resverlogix Corp.
|
Aug 25, 2016 12:45PM
|
Special Report on Drug Delivery: Penetrating the Impenetrable
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 07, 2018 10:07PM
|
Special Meetings for RVX and Zenith are 6/30 starting at 9AM Calgary time
|
2
|
Resverlogix Corp.
|
Jun 26, 2015 04:44PM
|
Someone please post a link to the slides.
|
1
|
Resverlogix Corp.
|
Dec 06, 2019 09:08AM
|
So BETonMACE failed the primary endpoint. What's next?
|
18
|
Resverlogix Corp.
|
Sep 30, 2019 05:16PM
|
Slides up for "LDL-C: DONE DEAL, NEXT EPIGENETICS?" Symposium
|
5
|
Resverlogix Corp.
|
Oct 10, 2018 10:15AM
|
Slides from Resverlogix Corporate Update 6/13/16
|
|
Resverlogix Corp.
|
Jun 13, 2016 01:29PM
|
Slides are up
|
3
|
Resverlogix Corp.
|
Oct 17, 2017 12:12PM
|
Slide deck will be posted at commencement of live presentation
|
3
|
Resverlogix Corp.
|
Sep 12, 2018 01:58PM
|
Slide Deck is Posted
|
5
|
Resverlogix Corp.
|
Oct 31, 2019 08:05PM
|
Slide Deck from Cowen Health Care Conference 3/8/17
|
6
|
Resverlogix Corp.
|
Mar 08, 2017 03:41PM
|